SCD and cancer: In this study, we evaluated the roles of SCD1 in an immunosuppressive TME and antitumor T cell responses and demonstrate that SCD1 and related fatty acids both in cancer cells and in immune cells are attractive targets as biomarkers and therapeutic targets for ICI-based combination immunotherapy.